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Background: Cardiovascular magnetic resonance (CMR) has been validated for the noninvasive assessment of total
arterial compliance and aortic stiffness, but their associations with cardiovascular outcomes is unknown. The purpose of
this study was to evaluate associations of CMR measures of total arterial compliance and two CMR measures of aortic
stiffness with respect to future cardiovascular events.
Methods: The study consisted of 2122 Dallas Heart Study participants without cardiovascular disease who underwent
CMR at 1.5 Tesla. Aortic stiffness was measured by CMR-derived ascending aortic distensibility and aortic arch
pulse wave velocity. Total arterial compliance was calculated by dividing left ventricular stroke volume by pulse
pressure. Participants were monitored for cardiovascular death, non-fatal cardiac events, and non-fatal extra-cardiac
vascular events over 7.8 ± 1.5 years. Cox proportional hazards regression was used to assess for associations between
CMR measures and cardiovascular events.
Results: Age, systolic blood pressure, and resting heart rate were independently associated with changes in ascending
aortic distensibility, arch pulse wave velocity, and total arterial compliance (all p < .0001). A total of 153 participants
(6.9%) experienced a cardiovascular event. After adjusting for traditional risk factors, total arterial compliance was
modestly associated with increased risk for composite events (HR 1.07 per 1SD, p = 0.03) while the association
between ascending aortic distensibility and composite events trended towards significance (HR 1.18 per 1SD,
p = 0.08). Total arterial compliance and aortic distensibility were independently associated with nonfatal cardiac
events (HR 1.11 per 1SD, p = 0.001 and HR 1.45 per 1SD, p = 0.0005, respectively), but not with cardiovascular death or
nonfatal extra-cardiac vascular events. Arch pulse wave velocity was independently associated with nonfatal extra-cardiac
vascular events (HR 1.18 per 1SD, p = 0.04) but not with cardiovascular death or nonfatal cardiac events.
Conclusions: In a multiethnic population free of cardiovascular disease, CMR measures of arterial stiffness are associated
with future cardiovascular events. Total arterial compliance and aortic distensibility may be stronger predictors of nonfatal
cardiac events, while pulse wave velocity may be a stronger predictor of nonfatal extra-cardiac vascular events.
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Arterial stiffening is one of the earliest detectable pathologic
changes within the artery wall and is a strong predictor of
future cardiovascular events and mortality [1,2]. Carotid-
femoral pulse wave velocity by applanation tonometry is
the most widely reported measure of arterial stiffness and
has shown to be a strong predictor of future cardiovascular
events and mortality over traditional risk factors [2].
Cardiovascular magnetic resonance (CMR) allows for the
evaluation of global stiffness and regional stiffness from
distinct user-defined anatomical regions. Several method-
ologies have recently been validated for the non-invasive
assessment of arterial stiffness using CMR, including total
arterial compliance (TAC), a measure of global arterial
stiffness [3,4], and ascending aortic distensibility (AD)
[5,6] and aortic arch pulse wave velocity (PWV), measures
of aortic stiffness [7-9]. However, the prognostic value of
these CMR measures in the general population remains
uncertain.
Arterial stiffness is a surrogate measure of end-organ
disease and may represent an index of the summed
effects of aging and risk factor exposure [1,2]. Different
measures of arterial stiffness may have different prognostic
value corresponding to differences in structural and geo-
metric properties of the arterial wall [10]. For example,
the impact of mechanical degeneration may have greatest
effect in the more compliant, elastin-rich proximal aorta
[11] while endothelial injury may largely impact stiffness
in smaller muscular arteries [12]. Risk factors such as
diabetes and hypercholesterolemia have been associated
with increases in both central and peripheral stiffness [13],
but associations between arterial stiffness and cardiovas-
cular outcomes have differed depending on the site of
arterial stiffness [14]. This has led to uncertainty over the
most appropriate measure of arterial stiffness to apply in
clinical practice and research trials.
The purpose of this study was therefore to evaluate
comparative cardiovascular outcome associations among
three CMR-derived measures of arterial stiffness within a
large, multiethnic population free of clinical cardiovascular
disease. In addition, we sought to evaluate associations
between these CMR measures and traditional cardiovas-
cular risk factors. We hypothesized that all three CMR
measures of arterial stiffness would be predictive of future
cardiovascular events, with possible differential associations
with components of the outcome.
Methods
Study design and study participants
The Dallas Heart Study is a longitudinal, multiethnic,
population-based probability sample of Dallas County resi-
dents. Details of the study design were previously described
[15]. Briefly, from an initial cohort of 6101 subjects ages
18–65 who participated in a detailed survey regardingmedical and family history, 3399 subjects ages 30–65
returned for a clinic visit involving blood and urine
samples, and 2971 subsequently participated in a third
visit for various imaging studies. Participants with baseline
cardiovascular disease (defined as prior stroke, myocardial
infarction, percutaneous coronary intervention, or cor-
onary artery bypass grafting) were excluded (n = 638).
The current study consisted of 2122 Dallas Heart Study
participants who successfully underwent cardiovascular
magnetic resonance (CMR). Written informed consent was
obtained from all subjects, and the study was approved by
the local Institutional Review Board.
CMR protocol
Participants underwent CMR using a 1.5 Tesla whole-body
system (Intera, Philips Medical Systems, Best, Netherlands).
All CMR studies were acquired with a four-element surface
array coil. Ascending aortic distensibility (AD) and aortic
arch pulse wave velocity (PWV) were assessed using a
breath-hold, velocity-encoded, phase-contrast gradient
echo sequence acquired perpendicular to the course of
the ascending aorta 4 cm above the aortic valve plane
(Figure 1) [16]. The ascending and descending thoracic
aorta were imaged in cross-section with a temporal
resolution of < 40 ms, 256 × 256 matrix, 34-cm field of
view, 20° flip angle, 10 ms repetition time, 5 ms echo
time, through-plane velocity encoding of ±150 cm/sec,
and slice thickness 8 mm. Images were acquired using
prospective ECG gating. The time-velocity curve was
interpolated to a temporal resolution of 10 ms by using
a cubic spine for subsequent analysis. The aortic arch
was also evaluated with an oblique sagittal, double
inversion-recovery spin echo image (“candy cane” view)
with the following parameters: 33 cm field of view,
electrocardiographically gated repetition time, 5.3 ms
echo time, 32 echo train length.
Cardiac magnetic resonance, including a cine steady state
free precession series of 10–13 short axis slices spanning
the cardiac apex through the ventricular base, was acquired
for measurement of left ventricular stroke volume (LVSV).
Images were acquired during 15–20 second end-expiratory
breath-holds using retrospective ECG gating. Additional
parameters included: temporal resolution < 40 ms, 256 ×
224 matrix (in-plane resolution 1.4 mm× 1.3 mm), 36-cm
field of view, 70° flip angle, 4.2 ms repetition time, 2.1 ms
echo time, 6 mm slice thickness and 4 mm slice gap.
Blood pressure measurements
Brachial blood pressure was measured non-invasively
using a non-ferromagnetic arm blood pressure cuff and
automated blood pressure monitor. Four separate blood
pressure measurements were acquired at various time
points: (1) before scanning, outside the magnet, (2) before
scanning, inside the magnet, (3) after scanning, inside the
Figure 1 CMR measures of aortic stiffness. Left, axial phase contrast images through the ascending and descending thoracic aorta. Middle,
time-velocity flow curves through the ascending (AAo) and descending (DAo) thoracic aorta with measurement of transit time (green line) as the
difference in time to half-max flow. Right, oblique sagittal view of the aortic arch with centerline measurement of aortic arch distance.
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magnet. The second and third blood pressure measure-
ments were averaged for each subject. Average pulse pres-
sure (PP) was calculated by the difference in average
systolic blood pressure (SBP) and average diastolic blood
pressure (DBP). In the case of participants whose blood
pressures were not successfully measured during CMR,
blood pressure measurements obtained closest in prox-
imity to the time of CMR scanning were used for the
brachial pulse pressure calculation.
Calculation of arterial stiffness measures
Area contours of the ascending and descending thoracic
aorta were manually traced through all phases of the
cardiac cycle. Time-velocity flow curves of the ascending
and descending thoracic aorta were produced using
Qflow (v.4.1.6, Medis, Leesburg). Maximum and mini-
mum cross-sectional areas of the ascending aorta were
measured (Aomax and Aomin, respectively). Transit time
(t) through the aortic arch was calculated as the time
between the ascending and descending upstroke veloci-
ties at half maximum [7]. A scout line indicating the
position of the phase-contrast acquisition image plane
was displayed on the candy cane view of the aortic
arch, and arch distance (d) was determined by drawing
a freehand line through the center of the aorta parallel
to the aortic walls between the positions in the ascending
and descending aorta at which arterial flow was measured,
as indicated by the scout line.
Total arterial compliance (TAC) [4] was calculated by
dividing left ventricular stroke volume (LVSV) by average
pulse pressure (PP):




Ascending aortic distensibility (AD) [17] was calculated
using the following equation:AD ¼ Aomax−Aomin½ 
PP  Aomin
Arch pulse wave velocity (PWV) [16,18] was calculated
by dividing arch distance (d) by transit time (t):
PWV ¼ d
t
Coronary artery calcium scores
Coronary artery calcium (CAC) scores were measured
using an Imatron C-150XP electron-beam CT scanner,
with results expressed in Agatston units [19]. Duplicate
scans were obtained 1–2 minutes apart, and the results
were averaged. A score >10 Agatston units was selected
as a data-derived threshold to define the presence of cor-
onary artery calcium in order to maximize signal-to-noise
ratio and reproducibility.
Cardiovascular events & surveillance
Subjects were followed for incident cardiovascular events
over a mean period of 7.8 ± 1.5 years. Fatal cardiovascular
events were ascertained using the National Death Index.
Deaths were classified as cardiovascular if they included
International Statistical Classification of Diseases, 10th
Revision codes I00-I99 [20]. Subjects were contacted
annually to participate in a detailed health survey in
regard to interval nonfatal cardiovascular events. In
addition, all subjects were tracked quarterly for hospital
admissions by using the Dallas-Fort Worth Hospital
Council Data Initiative database, which includes hos-
pital claims for 77 hospitals across 28 counties in North
Texas and represents 90% of the health care market
volume in this region [21]. Nonfatal cardiovascular events
assessed included: 1) nonfatal cardiac events (nonfatal
myocardial infarction, hospitalization for unstable angina,
coronary revascularization including percutaneous revas-
cularization and coronary artery bypass graft surgery,
Table 1 Baseline characteristics of the study population
(n = 2122)
Age (years) 44 ± 10
Body mass index (kg/m2) 30 ± 7
Systolic blood pressure (mmHg) 126 ± 17
Use of blood pressure lowering medication (%) 19%
Resting heart rate (beats per minute) 75 ± 11
Hypertension (%) 29%







Current smoking (%) 26%
Hypercholesterolemia (%) 12%
Low HDL-C (%) 39%
Family history of myocardial infarction (%) 31%
Coronary artery calcium score >10 (%) 19%
Mean abdominal aortic wall thickness (mm) 1.68 ± 0.30
Total arterial compliance (ml/mmHg) 1.60 ± 0.46
Ascending aortic distensibility (mmHg−1 × 10−3) 5.0 ± 3.1
Aortic arch pulse wave velocity (m/s) 4.9 ± 3.0
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hospitalization for atrial fibrillation); and 2) nonfatal
extra-cardiac vascular events. Nonfatal extra-cardiac
vascular events include both nonfatal cerebrovascular
events (nonfatal stroke, transient ischemic attack, cere-
brovascular revascularization) and nonfatal peripheral
vascular events (peripheral arterial revascularization and
abdominal aortic aneurysm repair). Primary records were
requested for all suspected cardiovascular events and
these events were adjudicated separately by two cardiol-
ogists [22]. Subjects lost to follow-up (n = 210) were
excluded from the analysis cohort.
Covariate definitions
Hypertension was defined as systolic blood pres-
sure ≥140 mm Hg, diastolic blood pressure ≥ 90 mm
Hg, or use of baseline blood pressure lowering medi-
cation. Hypercholesterolemia was defined as fasting
low density lipoprotein cholesterol ≥100 mg/dL or fasting
total cholesterol ≥200 mg/dL. Diabetes mellitus was
defined as a fasting glucose ≥125 mg/dL or use of
hypoglycemic medications. Body mass index (BMI)
was calculated using the equation weight (kg)/height
(m2). Subject gender, ethnicity and cigarette smoking
were determined by self report. Mean abdominal aortic
wall thickness (MAWT) was measured by CMR as previ-
ously described [22].
Statistics
TAC, AD, and PWV were analyzed as categorical variables
(gender and ethnicity-specific quartiles) and as continuous
variables. Multivariate linear regression was used to evalu-
ate associations between traditional risk factors and CMR
measures of arterial stiffness. Kaplan-Meyer cumulative
incidence curves were constructed for incident cardiovas-
cular events. The primary endpoint was composite events
(combined nonfatal cardiac events, nonfatal extra-cardiac
vascular events, and cardiovascular death). Secondary
endpoints were 1) cardiovascular death, 2) nonfatal car-
diac events, and 3) nonfatal extra-cardiac vascular events.
Cox proportional hazards regression was used to assess
associations of TAC, AD, and PWV in relation to incident
events after adjustment for age, sex, ethnicity, body mass
index, systolic blood pressure, use of blood pressure
lowering medications, resting heart rate, diabetes melli-
tus, cigarette smoking, and hypercholesterolemia. The
Supremum test confirmed a linear term for age was most
appropriate in our adjusted Cox proportional hazard
models. The contribution of CMR-derived arterial stiffness
measures to cardiovascular risk models including the
Framingham Risk Score were assessed using the likeli-
hood ratio chi-square statistic [23]. Raw percentages of
primary and secondary endpoints were assessed by the
Cochran-Armitage trend test. A value of p < 0.05 wasconsidered statistically significant. All statistical analyses
were performed with SAS (version 9.0, SAS Institute Inc.,
Cary, NC).Results
Baseline characteristics of the study population are pre-
sented (Table 1). During the surveillance period, 153
subjects (6.9%) experienced a first cardiovascular event,
of which 38 subjects (1.6%) succumbed to cardiovascular
death, 81 subjects (3.7%) experienced a nonfatal cardiac
event, and 47 subjects (2.2%) experienced a nonfatal extra-
cardiac vascular event.
No differences in CMR measures of arterial stiffness
were observed between subjects in the analysis cohort
(n = 2122) and subjects lost to follow-up (n = 211), all
p > 0.20. Increasing age, systolic blood pressure, and
resting heart rate were independently associated with
lower TAC, lower AD, and faster PWV (all p < .0001)
(Table 2). Male gender was independently associated
with lower AD (p < .0001), but not with either PWV
(p = 0.25) or TAC (p = 0.89). Diabetes was independently
associated with lower TAC (p = 0.0002) and lower AD
(p = 0.04), but not with PWV (p = 0.60). Increasing body
mass index was independently associated with lower
Table 2 Linear regression associations between traditional risk factors and CMR measures of arterial stiffness
Variable Ascending aortic





Univariate Multivariate* Univariate Multivariate* Univariate Multivariate*
β P β P β P β P β P β P
Age (per 10 year increase) −1.9 <.0001 −1.5 <.0001 0.25 <.0001 0.20 <.0001 −0.20 <.0001 −0.13 <.0001
Gender (male) −1.0 <.0001 −0.83 <.0001 0.04 0.01 0.02 0.25 0.12 <.0001 0.003 0.89
Ethnicity (African American) −0.82 <.0001 −0.04 0.68 0.16 <.0001 0.06 <.0001 −0.14
SBP (per 10 mmHg increase) −0.98 <.0001 −0.56 <.0001 0.11 <.0001 0.07 <.0001 −0.14 <.0001 −0.11 <.0001
Use of hypertension medications −2.3 <.0001 −0.25 0.20 0.28 <.0001 0.03 0.13 −0.31 <.0001 −0.01 0.72
Resting heart rate (per 10 beat
per minute increase)
−0.39 <.0001 −0.38 <.0001 0.018 0.01 0.027 <.0001 −0.06 <.0001 −0.05 <.0001
Current smoking −0.19 0.17 0.002 0.98 0.06 0.0008 0.02 0.37 0.005 0.87 −0.001 0.94
Diabetes mellitus −2.2 <.0001 −0.32 0.04 0.18 <.0001 −0.01 0.60 −0.41 <.0001 −0.11 0.0002
Total cholesterol (per 10 mg/dL increase) −0.12 <.0001 −0.11 0.28 0.014 <.0001 0.001 0.66 −0.014 <.0001 −0.005 0.03
HDL-C (per 10 mg/dL increase) 0.08 0.04 −0.10 0.76 0.02 0.0005 0.016 0.003 0.006 0.50 0.016 0.009
BMI (per 1 kg/m2 increase) −0.06 <.0001 −0.01 0.16 0.0005 = 0.96 −0.005 0.0004 −0.00 0.12 0.013 <.0001
β=beta coefficient for linear regression.
P=statistical significance.
*Multivariate analyses are adjusted for all covariates listed in the first column.
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with AD (p = 0.16).
Progression from highest to lowest quartiles of TAC
and AD, and from lowest to highest quartile of PWV
were associated with incremental increased risk for com-
posite cardiovascular events (Figure 2). When analyzed
as continuous variables, changes in TAC, AD, and PWV
were each associated with increased risk for composite
events (all p < .0001). After adjusting for traditional risk
factors, TAC maintained a modest association with com-
posite events (HR 1.07 per 1SD change, 95% CI 1.01-1.14,
p = 0.03) (Table 3), while the association between AD and
composite events trended towards significance (HR 1.18,
95% CI 0.95-1.46, p = 0.08). PWV was not independently
associated with composite events after adjusting for
traditional risk factors (HR 1.11 per 1SD change, 95%
CI 0.89-1.32, p = 0.28). However, PWV independentlyFigure 2 Cumulative incidence curves for composite cardiovascular e
ascending aortic distensibility, and (C) arch pulse wave velocity.conferred increased risk for nonfatal extra-cardiac vascu-
lar events (HR 1.18 per 1SD change, 95% CI 1.02-1.55,
p = 0.04). Neither TAC nor AD were independently
associated with nonfatal extra-cardiac vascular events
after multivariable adjustment. However, TAC and AD
independently conferred increased risk for nonfatal
cardiac events (HR 1.11 per 1SD change, 95% CI 1.04-
1.19, p = 0.001; and HR 1.45 per 1SD change, 95% CI
1.18-1.78, p = 0.0005, respectively).
When PWVwas included in amodel with the Framingham
Risk Score, there was a modest increase in the C statistic
for composite events which approached significance
(0.771 vs. 0.755, p = 0.05). Although modest increases
in the C statistic were also observed when AD and TAC
were included in models with the Framingham Risk Score,
these differences were not significant (0.772 vs. 0.755,
p = 0.55 and 0.769 vs. 0.755, p = 0.36, respectively).vents based on quartile of (A) total arterial compliance, (B)
Table 3 Hazard ratios for cardiovascular events
Unadjusted Adjusted*
Total arterial compliance† HR 95% CI P HR 95% CI P
Composite events 1.14 1.10-1.18 <.0001 1.07 1.01-1.14 0.03
Cardiovascular death 1.10 1.01-1.20 0.02 0.97 0.73-1.30 0.85
Nonfatal cardiac events 1.15 1.10-1.20 <.0001 1.11 1.04-1.19 0.001
Nonfatal extra-cardiac vascular events 1.10 1.02-1.19 0.02 0.97 0.74-1.28 0.86
Ascending aortic distensibility‡
Composite events 1.63 1.50-1.77 <.0001 1.18 0.95-1.46 0.08
Cardiovascular death 1.49 1.25-1.77 <.0001 0.72 0.41-1.28 0.27
Nonfatal cardiac events 1.69 1.52-1.87 <.0001 1.45 1.18-1.78 0.0005
Nonfatal extra-cardiac vascular events 1.52 1.31-1.76 <.0001 1.09 0.76-1.57 0.63
Arch pulse wave velocity§
Composite events 1.23 1.15-1.31 <.0001 1.11 0.89-1.32 0.28
Cardiovascular death 1.25 1.11-1.41 <.0001 0.92 0.63-1.33 0.64
Nonfatal cardiac events 1.19 1.08-1.32 <.0001 1.00 0.76-1.32 0.97
Nonfatal extra-cardiac vascular events 1.76 1.24-2.11 <.0001 1.18 1.02-1.55 0.04
*adjusted for age, sex, ethnicity, systolic blood pressure, use of blood pressure medication, resting heart rate, diabetes mellitus, current smoking, body mass index,
and hypercholesterolemia.
†hazard ratios per 1SD (0.46 ml/mmHg) decrease in total arterial compliance.
‡hazard ratios per 1SD (3.1 mmHg−1 × 10−3) decrease in aortic distensibility.
§hazard ratios per 1SD (3.0 m/s) increase in pulse wave velocity.
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Our study is the first to evaluate the prognostic value
of CMR-derived measures of TAC, AD, and PWV
within a large, multiethnic population without clinical
cardiovascular disease. Results from our study demon-
strate that all three measures are associated with future
cardiovascular events. After adjusting for traditional
risk factors, TAC remained independently predictive of
composite events, while the relationship between AD
and composite events approached significance. Although
PWV was not independently predictive of composite
events, changes in PWV were independently associated
with nonfatal extra-cardiac vascular events. Further,
incorporation of PWV into a risk model with the
Framingham Risk Score yielded modest improvement
in the C statistic which approached significance (p = 0.05).
Arterial stiffness, a measure of vascular function, is
central to the onset of atherosclerosis and is a primary
determinant of age-related increases in systolic blood
pressure and pulse pressure [24]. Aortic stiffening is a
major contributor to arterial stiffness, and several prior
population studies have documented a strong independent
predictive role of aortic stiffness, measured by carotid-
femoral PWV, with respect to cardiovascular morbidity
and mortality. For example, in the Rotterdam Study,
Mattace-Raso et al [25] used pressure transducer-derived
carotid-femoral PWV to demonstrate that the hazard ratio
for coronary heart disease among subjects in the highest
tertile of PWV was 2.45 after adjusting for age, gender,
mean arterial pressure, and heart rate. Likewise, in theFramingham Heart Study, Mitchell et al [26] demonstrated
that faster carotid-femoral PWV conferred increased risk
for an initial cardiovascular event (HR 1.48 per SD increase)
after adjusting for traditional risk factors. In the Health
ABC Study, Sutton-Tyrrell et al [27] demonstrated that
Doppler flow-derived carotid-femoral PWV was independ-
ently associated with greater cardiovascular mortality and
stroke among a large cohort of healthy adults. Carotid-
femoral PWV has further been shown to improve risk
stratification among patients already identified as having
higher baseline cardiovascular risk, such as those with
end-stage renal disease [28], and hypertension [29].
However, the prognostic value of CMR measures of
arterial stiffness has not been explored in prior studies.
There are several advantages of CMR for the noninvasive
assessment of arterial stiffness. First, CMR has capability
to measure local and regional arterial stiffness at multiple
vascular segments during a single CMR imaging session.
In addition, CMR affords freedom from operator bias
and offers accurate determination of path length for the
calculation of PWV, which is not available using other
modalities [30]. The current technique for measuring aortic
stiffness using tonometry requires specialized equipment
and training which limits its clinical utility. CMR-derived
TAC [31,32], ascending AD [3,33], and arch PWV [3,18]
have each been validated against traditional methods
for assessing arterial stiffness and demonstrate high repro-
ducibility. Further, all three measures are easily obtained
during routine CMR without the need for specialized
post-processing software. CMR-derived measures are
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modalities and evaluate changes over time.
While assessment of arterial stiffness is suggested to
improve risk stratification as a measure of end-organ
disease [34], it is important to note that susceptibility
to insult from cardiovascular risk factors differs among
different arterial segments [4]. Since arterial stiffness
may be a marker of cumulative insult, having different
susceptibilities to insults at specific arterial segments
may have important implications for predicting cardio-
vascular outcomes. Our results highlight similarities
and differences for risk factor associations among CMR
measures of arterial stiffness. Age, systolic blood pressure,
and heart rate were determinants of all three CMR mea-
sures, which is concordant with prior studies [17,35,36].
However, differences in risk factor susceptibility were also
observed among our CMR measures. For example, we
observed African American ethnicity to be an inde-
pendent determinant of lower TAC and faster PWV,
but not lower AD. This finding is discordant from prior
observations by Malayeri et al [35] who reported a sig-
nificant association between African American ethnicity
and lower AD within the MESA cohort. This discrepancy
may be accounted for by differences in our multivariate
models, as our study included resting heart rate and
diabetes mellitus as covariates, both of which are independ-
ent determinants of AD. Further, we observed diabetes
mellitus was independently associated with lower TAC
and lower AD, but not with faster PWV. Stacey et al
[37] described a similar association between diabetes and
AD within the MESA cohort. While the pathohysiologic
mechanism for this observation remains unclear, elevated
glycemic status may have a preferential deleterious effect
on the elastin-rich ascending aorta and a lesser effect on
distal aortic segments.
While TAC was the only CMR measure which demon-
strated a significant independent association with our
primary endpoint of composite events, the relationship
between AD and composite events approached significance
(p = 0.08). However, our results also suggest that different
measures of arterial stiffness by CMR may be associated
with different subtypes of cardiovascular outcomes. For
example, both TAC and AD conferred independent
increased risk for nonfatal cardiac events but not non-
fatal extra-cardiac vascular events. In contrast, PWV
conferred independent increased risk for nonfatal extra-
cardiac vascular events but not nonfatal cardiac events.
None of our CMR measures were predictive of cardiovas-
cular death after adjusting for traditional risk factors.
These results suggest CMR measures of local and regional
aortic stiffness (AD and PWV, respectively) and global
arterial stiffness (measured by TAC) may have distinct
sensitivities for evaluating the downstream pathologic
manifestations of arterial stiffening. For example, processesresulting in lower TAC and lower AD may preferentially
manifest through deleterious effects on the heart, whereas
process resulting in faster PWV may preferentially manifest
through deleterious effects on the brain and distal arteries.
Prior work from our lab demonstrated PWV is a strong
independent predictor of chronic ischemic insult to the
brain, as indicated by white matter hyperintensity volume
[16]. Thus, different measures of arterial stiffness may
function as better surrogate markers of end-organ disease
in different organ systems.
There was modest increase in the C statistic by includ-
ing PWV in a model with the Framingham Risk Score
which approached significance. However, no significant
increment in the C statistic was observed by including
TAC or AD in similar models. Thus, our results do not
encourage widespread screening for cardiovascular risk
using solely CMR stiffness in the general population.
However, CMR measures of arterial stiffness can be easily
obtained during routine CMR exams and can potentially
serve as useful subclinical measures to investigate different
phases of cardiovascular disease and end-organ damage.
Future studies are necessary to compare the incremental
prognostic value of CMR measures of arterial stiffness
with markers of atherosclerosis burden, such as coronary
artery calcium score.
Limitations
There were several limitations of this study. First, a non-
invasive measure of peripheral blood pressure was used
to calculate AD and TAC instead of an invasive measure
of central aortic pressure. Despite this limitation, prior
studies have indicated that noninvasive blood pressure
measures are adequate approximations and predict future
cardiovascular events [38,39]. Second, a limited number of
adverse events throughout the surveillance period limited
our statistical power to explore associations with event
subtypes and within subgroups. Thus, the present data
may underestimate the predictive value of arterial stiff-
ness, and future studies with longer surveillance periods
are necessary to examine the prognostic value of these
measures among patients with different baseline cardio-
vascular risk. Since the number of observed nonfatal
extra-cardiac vascular events was particularly low during
the surveillance period (n = 47), nonfatal cerebrovascular
events were combined with nonfatal peripheral vascular
events into a single event subcategory so as to improve
power for multivariate regression analyses. However, arter-
ial stiffening at different vascular sites may elicit differen-
tial influences on one’s risk for future cerebrovascular and
peripheral vascular events. Future studies are necessary to
examine associations between CMR measures of arterial
stiffness and nonfatal cerebrovascular and peripheral vas-
cular events as separate outcome categories. Third, since
our study population was free of clinical cardiovascular
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stiffness measures may be lower. A recent meta-analysis
by Vlachopoulos et al [2] demonstrated the predictive
ability of carotid-femoral PWV was greatest among
subjects with higher baseline cardiovascular risk. Future
studies are necessary to examine the prognostic value
of CMR measures among higher risk subgroups. Forth,
TAC is a crude indicator of global arterial stiffness based
on a modified two-factor Windkessel model combining
resistance and capacitance. As such, TAC is limited in
describing all components of arterial mechanics [40].
Finally, there were limitations of our 2D phase contrast
sequence used to calculate PWV and AD. For example,
no through-plane motion correction was used during the
acquisition, which likely compromised area measurements
of the ascending aorta [41]. Adoption of a more advanced
phase contrast technique with higher temporal resolution
and through-plane motion correction would circumvent
this limitation in future studies [42].
Conclusions
In conclusion, we demonstrated that CMR measures of
TAC, AD, and PWV are associated with adverse cardio-
vascular events. Further, different CMR measures appear
to have different associations with traditional risk factors
and specific subtypes of cardiovascular outcomes. While
TAC and AD demonstrated stronger associations with
nonfatal cardiac events, PWV demonstrated a stronger
association with nonfatal extra-cardiac vascular events.
Future studies are necessary to evaluate the prognostic
value of these measures for earlier subclinical markers of
end-organ disease. In addition, the prognostic value of
these CMR measures should be explored among subjects
with higher baseline cardiovascular risk.
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